Eversept Partners LP Takes $13.46 Million Position in Select Medical Holdings Corporation $SEM

Eversept Partners LP bought a new stake in Select Medical Holdings Corporation (NYSE:SEM) during the fourth quarter, Holdings Channel reports. The institutional investor bought 906,100 shares of the health services provider’s stock, valued at approximately $13,456,000.

A number of other large investors also recently modified their holdings of the stock. Smartleaf Asset Management LLC lifted its holdings in shares of Select Medical by 37.8% in the fourth quarter. Smartleaf Asset Management LLC now owns 2,870 shares of the health services provider’s stock valued at $43,000 after purchasing an additional 788 shares in the last quarter. State of Alaska Department of Revenue lifted its holdings in shares of Select Medical by 1.5% in the fourth quarter. State of Alaska Department of Revenue now owns 63,370 shares of the health services provider’s stock valued at $940,000 after purchasing an additional 935 shares in the last quarter. Wilmington Savings Fund Society FSB lifted its holdings in shares of Select Medical by 20.9% in the third quarter. Wilmington Savings Fund Society FSB now owns 5,784 shares of the health services provider’s stock valued at $74,000 after purchasing an additional 999 shares in the last quarter. Universal Beteiligungs und Servicegesellschaft mbH lifted its holdings in shares of Select Medical by 9.7% in the fourth quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 11,475 shares of the health services provider’s stock valued at $171,000 after purchasing an additional 1,014 shares in the last quarter. Finally, California State Teachers Retirement System lifted its holdings in shares of Select Medical by 1.4% in the second quarter. California State Teachers Retirement System now owns 102,230 shares of the health services provider’s stock valued at $1,552,000 after purchasing an additional 1,418 shares in the last quarter. Institutional investors own 89.48% of the company’s stock.

Select Medical Stock Performance

Shares of SEM opened at $16.54 on Thursday. The company has a current ratio of 1.15, a quick ratio of 1.15 and a debt-to-equity ratio of 0.88. The company has a market capitalization of $2.05 billion, a price-to-earnings ratio of 15.60, a PEG ratio of 0.96 and a beta of 1.01. The stock has a 50 day moving average of $16.48 and a 200 day moving average of $15.86. Select Medical Holdings Corporation has a 12 month low of $11.65 and a 12 month high of $16.99.

Select Medical (NYSE:SEM) last issued its quarterly earnings results on Thursday, April 30th. The health services provider reported $0.36 EPS for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.07). The business had revenue of $1.42 billion for the quarter, compared to analysts’ expectations of $1.41 billion. Select Medical had a net margin of 2.42% and a return on equity of 6.62%. The business’s revenue was up 5.0% compared to the same quarter last year. During the same period in the previous year, the business posted $0.44 earnings per share. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. As a group, sell-side analysts forecast that Select Medical Holdings Corporation will post 1.26 earnings per share for the current year.

Select Medical announced that its board has initiated a share buyback program on Thursday, February 19th that permits the company to repurchase $1.00 billion in shares. This repurchase authorization permits the health services provider to purchase up to 49.5% of its shares through open market purchases. Shares repurchase programs are typically a sign that the company’s board of directors believes its stock is undervalued.

Select Medical Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, May 28th. Shareholders of record on Thursday, May 14th were given a $0.0625 dividend. This represents a $0.25 dividend on an annualized basis and a yield of 1.5%. The ex-dividend date of this dividend was Thursday, May 14th. Select Medical’s dividend payout ratio (DPR) is currently 23.58%.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on SEM shares. Zacks Research upgraded Select Medical from a “strong sell” rating to a “hold” rating in a report on Monday, May 4th. Wall Street Zen lowered Select Medical from a “buy” rating to a “hold” rating in a report on Monday, March 9th. Weiss Ratings raised Select Medical from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, June 4th. Mizuho reaffirmed a “neutral” rating and set a $16.50 price target (down from $17.00) on shares of Select Medical in a research report on Tuesday, May 12th. Finally, Benchmark downgraded Select Medical from a “buy” rating to a “hold” rating in a research report on Wednesday, March 4th. One research analyst has rated the stock with a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $15.50.

Select Medical Profile

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.